Modulation of oxidative stress as an anticancer strategy, Nat. Rev. Drug Discov, vol.12, issue.12, pp.931-947, 2013. ,
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?, Nat. Rev. Drug Discov, vol.8, issue.7, pp.579-591, 2009. ,
Redox paradox: a novel approach to therapeutics-resistant cancer, Antioxid Redox Signal, vol.29, issue.13, pp.1237-1272, 2018. ,
Ascorbic acid: chemistry, biology and the treatment of cancer, Biochim. Biophys. Acta, vol.1826, issue.2, pp.443-457, 2012. ,
Myths, artifacts, and fatal flaws: identifying limitations and opportunities in vitamin C research, Nutrients, vol.5, issue.12, pp.5161-5192, 2013. ,
Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo, Proc. Natl. Acad. Sci. U.S.A, vol.104, issue.21, pp.8749-8754, 2007. ,
Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice, Proc. Natl. Acad. Sci. U.S.A, vol.105, issue.32, pp.11105-11109, 2008. ,
Losing and finding a way at C: new promise for pharmacologic ascorbate in cancer treatment, Free Radic, Biol. Med, vol.47, issue.1, pp.27-29, 2009. ,
Augmentation of intracellular iron using iron sucrose enhances the toxicity of pharmacological ascorbate in colon cancer cells, Redox Biol, vol.14, pp.82-87, 2018. ,
Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH, Science, vol.350, issue.6266, pp.1391-1396, 2015. ,
Tumor cells have decreased ability to metabolize H 2 O 2 : implications for pharmacological ascorbate in cancer therapy, Redox Biol, vol.10, pp.274-284, 2016. ,
SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment, Oncogene, vol.32, issue.12, pp.1508-1517, 2013. ,
Vitamin C transporters in cancer: current understanding and gaps in knowledge, Front Oncol, vol.7, p.74, 2017. ,
SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts, Cancer Lett, vol.398, pp.1-11, 2017. ,
O 2 ?-and H 2 O 2 -mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate, Cancer Cell, vol.32, issue.2, p.268, 2017. ,
Redox active metals and H 2 O 2 mediate the increased efficacy of pharmacological ascorbate in combination with gemcitabine or radiation in pre-clinical sarcoma models, Redox Biol, vol.14, pp.417-422, 2018. ,
, ROS stress in cancer cells and therapeutic implications, vol.7, pp.97-110, 2004.
Metabolomic alterations in human cancer cells by vitamin C-induced oxidative stress, Sci. Rep, vol.5, p.13896, 2015. ,
High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy, Sci. Transl. Med, vol.6, issue.222, pp.222-218, 2014. ,
Pharmacological ascorbate radiosensitizes pancreatic cancer, Cancer Res, vol.75, issue.16, pp.3314-3326, 2015. ,
Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer, Clin. Cancer Res, vol.16, issue.2, pp.509-520, 2010. ,
RelB expression determines the differential effects of ascorbic acid in normal and cancer cells, Cancer Res, vol.77, issue.6, pp.1345-1356, 2017. ,
High dose parenteral ascorbate inhibited pancreatic cancer growth and metastasis: mechanisms and a phase I/IIa study, Sci. Rep, vol.7, issue.1, p.17188, 2017. ,
PRX1 knockdown potentiates vitamin K3 toxicity in cancer cells: a potential new therapeutic perspective for an old drug, J. Exp. Clin. Cancer Res, vol.34, p.152, 2015. ,
Identification of redox-sensitive cysteines in the Arabidopsis proteome using OxiTRAQ, a quantitative redox proteomics method, Proteomics, vol.14, issue.6, pp.750-762, 2014. ,
The PRIDE database and related tools and resources in 2019: improving support for quantification data, Nucleic Acids Res, vol.47, issue.D1, pp.442-450, 2019. ,
Singlet oxygen-mediated oxidation during UVA radiation alters the dynamic of genomic DNA replication, PLoS One, vol.10, issue.10, p.140645, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01264850
Auranofin/vitamin C: a novel drug combination targeting triple-negative breast cancer, J Natl Cancer Inst, vol.111, issue.6, pp.597-608, 2019. ,
Fluorescent protein-based redox probes, Antioxid Redox Signal, vol.13, issue.5, pp.621-650, 2010. ,
Genetically encoded fluorescent indicator for intracellular hydrogen peroxide, Nat. Methods, vol.3, issue.4, pp.281-286, 2006. ,
The redox proteome, J. Biol. Chem, vol.288, issue.37, pp.26512-26520, 2013. ,
The cysteine proteome, Free Radic, Biol. Med, vol.84, pp.227-245, 2015. ,
Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer, Oncotarget, vol.7, issue.30, pp.47954-47965, 2016. ,
CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set, Cancer Res, vol.72, issue.14, pp.3499-3511, 2012. ,
CellMiner: a relational database and query tool for the NCI-60 cancer cell lines, BMC Genomics, vol.10, p.277, 2009. ,
Peroxiredoxin 1 knockdown potentiates beta-lapachone cytotoxicity through modulation of reactive oxygen species and mitogen-activated protein kinase signals, Carcinogenesis, vol.34, issue.4, pp.760-769, 2013. ,
Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents, Br J Cancer, vol.119, issue.7, pp.873-884, 2018. ,
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues, Proc. Natl. Acad. Sci. U.S.A, vol.102, issue.38, pp.13604-13609, 2005. ,
Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries, Adv Nutr, vol.2, issue.2, pp.78-88, 2011. ,
Controlling gene expression in response to stress, Nat. Rev. Genet, vol.12, issue.12, pp.833-845, 2011. ,
Translational reprogramming in cellular stress response, Wiley Interdiscip Rev RNA, vol.5, issue.3, pp.301-315, 2014. ,
, Translational control in cancer, vol.10, issue.4, pp.254-266, 2010.
Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor, Cell Death Dis, issue.3, p.409, 2012. ,
Targeting the translation machinery in cancer, Nat. Rev. Drug Discov, vol.14, issue.4, pp.261-278, 2015. ,
The combination of ascorbate and menadione causes cancer cell death by oxidative stress and replicative stress, Free Radic, Biol. Med, vol.134, pp.350-358, 2019. ,
Membrane transport of hydrogen peroxide, Biochim. Biophys. Acta, vol.1758, issue.8, pp.994-1003, 2006. ,
A family of mammalian Na+-dependent L-ascorbic acid transporters, Nature, vol.399, issue.6731, pp.70-75, 1999. ,
Increased expression of mitochondrial sodium-coupled ascorbic acid transporter-2 (mitSVCT2) as a central feature in breast cancer, Free Radic, Biol. Med, vol.135, pp.283-292, 2019. ,
Human HL-60 myeloid leukemia cells transport dehydroascorbic acid via the glucose transporters and accumulate reduced ascorbic acid, Blood, vol.84, issue.5, pp.1628-1634, 1994. ,
Recycling of vitamin C from its oxidized forms by human endothelial cells, Biochim. Biophys. Acta, vol.1640, issue.2-3, pp.153-161, 2003. ,
Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer, Cancer Chemother. Pharmacol, vol.72, issue.1, pp.139-146, 2013. ,
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy, Ann. Oncol, vol.19, issue.11, pp.1969-1974, 2008. ,
, Biology, vol.26, p.101290, 2019.